160 related articles for article (PubMed ID: 30475754)
21. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.
Liu X; Luo HN; Tian WD; Lu J; Li G; Wang L; Zhang B; Liang BJ; Peng XH; Lin SX; Peng Y; Li XP
Cancer Biol Ther; 2013 Dec; 14(12):1133-42. PubMed ID: 24025417
[TBL] [Abstract][Full Text] [Related]
22. An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.
Liu L; Wang H; Yan C; Tao S
Technol Cancer Res Treat; 2020; 19():1533033820956998. PubMed ID: 32985354
[TBL] [Abstract][Full Text] [Related]
23. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.
Plieskatt JL; Rinaldi G; Feng Y; Levine PH; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Bethony JM; Mulvenna JP
J Transl Med; 2014 Jan; 12():3. PubMed ID: 24393330
[TBL] [Abstract][Full Text] [Related]
24. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
25. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
26. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
[TBL] [Abstract][Full Text] [Related]
27. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
[TBL] [Abstract][Full Text] [Related]
28. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
29. Direct quantification of circulating miRNAs in different stages of nasopharyngeal cancerous serum samples in single molecule level with total internal reflection fluorescence microscopy.
Ho SL; Chan HM; Ha AW; Wong RN; Li HW
Anal Chem; 2014 Oct; 86(19):9880-6. PubMed ID: 25207668
[TBL] [Abstract][Full Text] [Related]
30. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
Chen Y; Chen J; Liu Y; Li S; Huang P
Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
32. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.
Wang HY; Yan LX; Shao Q; Fu S; Zhang ZC; Ye W; Zeng YX; Shao JY
Clin Chem; 2014 May; 60(5):773-82. PubMed ID: 24563490
[TBL] [Abstract][Full Text] [Related]
33. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
34. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
Zeng X; Xiang J; Wu M; Xiong W; Tang H; Deng M; Li X; Liao Q; Su B; Luo Z; Zhou Y; Zhou M; Zeng Z; Li X; Shen S; Shuai C; Li G; Fang J; Peng S
PLoS One; 2012; 7(10):e46367. PubMed ID: 23056289
[TBL] [Abstract][Full Text] [Related]
35. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.
Luan J; Wang J; Su Q; Chen X; Jiang G; Xu X
Oncotarget; 2016 Mar; 7(9):10513-21. PubMed ID: 26824418
[TBL] [Abstract][Full Text] [Related]
37. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
38. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
39. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
[TBL] [Abstract][Full Text] [Related]
40. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]